MedTrace Logo

Comparison of the Efficacy of Calcium Hydroxide With Silver Nanoparticle and Conventional Calcium Hydroxide Intra Canal Medications on Post-Operative Pain in Symptomatic Root Canal Treatment Failure Cases:

NCT04213716 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-01-02

No results posted yet for this study

Summary

The aim of this study is to measure and compare the effectiveness of nanosilver combined calcium hydroxide and conventional calcium hydroxide intracanal medications in reducing postoperative pain in patients with Symptomatic Root Canal treatment Failure .

Conditions

  • Retreatment
  • Root Canal Retreatment
  • Nonsurgical Retreatment
  • Endodontic Failure
  • Symptomatic Endodontic Failure
  • Nanosilver
  • Intracanal Medicament
  • Intracanal Dressing
  • AgNPs
  • Calcium Hydroxide
  • Ca (OH)2
  • Discomfort
  • Pain
  • Flare up
  • Postoperative
  • Ache
  • Post-operative
  • Post Obturation

Interventions

COMBINATION_PRODUCT

silver nano particulate solution mixed with calcium hydroxide powder

1ml of nanosilver solution 30ppm concentration mixed with 100 mg of calcium hydroxide powder used as intracanal medication

COMBINATION_PRODUCT

conventional calcium hydroxide

1ml of distilled water mixed with 100 mg of calcium hydroxide powder and used as intracanal medication after root canal retreatment

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Rawda baghdady, M.S.c · Cairo University

  • Jealan El shafei, professor · Cairo University

  • Alaa El baz, assist prof · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-15
Primary Completion
2016-06-30
Completion
2016-12-12

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04213716 on ClinicalTrials.gov